Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
NCT07154511
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation. The main questions it aims to answer are: Does tributyrin improve memory/thinking test scores and walking/balance ability? What medical problems do participants have when taking tributyrin?
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Parkinson Disease
- Parkinson Disease Dementia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1/2
- Ages
- 45 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Prabesh Kanel
- Last updated on ClinicalTrials.gov
- November 12, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Michigan · 1
- Domino's Farms · Ann Arbor, MI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.